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Nanoscale polymeric micelles have attracted more and more attention as a promising nanocarrier for controlled
delivery of antineoplastic drugs. Herein, the doxorubicin (DOX)-loaded poly(D-lactide)-based micelle (PDM/DOX),
poly(L-lactide)-based micelle (PLM/DOX), and stereocomplex micelle (SCM/DOX) from the equimolar mixture of
the enantiomeric four-armed poly(ethylene glycol)-polylactide (PEG-PLA) copolymers were successfully fabricated.
In phosphate-buffered saline (PBS) at pH 7.4, SCM/DOX exhibited the smallest hydrodynamic diameter (Dh) of
90 ± 4.2 nm and the slowest DOX release compared with PDM/DOX and PLM/DOX. Moreover, PDM/DOX, PLM/DOX,
and SCM/DOX exhibited almost stable Dhs of around 115, 105, and 90 nm at above normal physiological condition,
respectively, which endowed them with great potential in controlled drug delivery. The intracellular DOX fluorescence
intensity after the incubation with the laden micelles was different degrees weaker than that incubated with free
DOX · HCl within 12 h, probably due to the slow DOX release from micelles. As the incubation time reached to 24 h,
all the cells incubated with the laden micelles, especially SCM/DOX, demonstrated a stronger intracellular DOX
fluorescence intensity than free DOX · HCl-cultured ones. More importantly, all the DOX-loaded micelles, especially
SCM/DOX, exhibited potent antineoplastic efficacy in vitro, excellent serum albumin-tolerance stability, and satisfactory
hemocompatibility. These encouraging data indicated that the loading micelles from nonlinear enantiomeric copolymers,
especially SCM/DOX, might be promising in clinical systemic chemotherapy through intravenous injection.
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Stereocomplex micelleBackground
In recent years, a variety of nanoscale polymeric drug
delivery systems (DDSs) have made great strides in the
design and fabrication, such as micelles [1,2], vesicles
[3,4], nanogels [5,6], and so on. Among them, micelles
as a promising type of DDSs have attracted widely atten-
tion for their satisfactory solubilization, targetability,
P-glycoprotein inhibition, and efficient drug endocytosis
[7]. Micelles are constructed through the spontaneous* Correspondence: chunxi_wang@126.com; tongjunliu@163.com
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provided the original work is properly creditedself-assembly of amphiphilic copolymers in an aqueous
condition [8,9]. In addition, micelles exhibit a core-shell
architecture, that is, they are composed of an inner core
and an outer shell [10]. The outer shell is related to the
pharmacokinetic behavior in vivo, and the inner core
affects stability, drug loading efficiency, and release be-
havior [7]. The particular structural feature contributes
to the satisfactory characteristics mentioned above.
Despite micelles have achieved great progress in the
past few decades, the stability of them is still a major im-
pediment for their extensive application in the field of
controlled drug delivery [11]. Consequently, various
weak interplays, such as hydrophobic, electrostatic, host-
guest, and stereocomplex interactions, have been ex-
plored to enhance the stability of micelle and overcomecle distributed under the terms of the Creative Commons Attribution License
hich permits unrestricted use, distribution, and reproduction in any medium,
.
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stereocomplex interaction-assisted polymeric micelles
have gained increasing attention for their improved ther-
mal and mechanical resistance, elevated stability, and re-
duced degradation rate [12,13]. Typically, the enantiomeric
poly(L-lactide) (PLLA) and poly(D-lactide) (PDLA) copo-
lymers have been the most widely explored polymeric
matrices for stereocomplexation since Ikada et al. first
reported them in 1987 [14,15]. Chen and coworkers pre-
pared the stereocomplex micelles (SCMs) of the enantio-
meric poly(ethylene glycol)-polylactide (PEG-PLA) block
copolymers with different lengths of PLA chains for rifam-
pin delivery, which showed lower critical micelle concen-
trations (CMCs), smaller micelle sizes, and higher loading
capacities and encapsulation efficiencies compared with
the micelles with a single component [16]. Moreover, the
release performance of the drug-loaded SCM was related
to the molecular weight and composition of block copoly-
mer, and the morphology of micelle. Recently, the same
group prepared the SCMs based on amphiphilic dextran-
block-polylactide (Dex-b-PLA) copolymers, which could
deliver DOX with high stability and sustained release
profiles in vitro [17]. Moreover, in our previous work, a
DOX-loaded SCM based on four-armed PEG-b-PLA was
fabricated and exhibited a better antineoplastic effect than
the laden micelles with a single matrix [18]. However, the
previous platforms exhibit some limitations, such as com-
plex synthesis process and large diameter.
In the current work, in order to further verify the
impact of stereocomplex on the performance of micelle
and optimize the performances of SCM, the DOX-loaded
SCM (i.e., SCM/DOX) based on equimolar four-armed
PEG-PDLA/PEG-PLLA exhibiting different molecular
weights and compositions with previous systems was
prepared by nanoprecipitation. The DOX-loaded micelles
derived from individual four-armed PEG-PDLA and PEG-
PLLA were referred as PDM/DOX and PLM/DOX,
respectively. The laden micelles exhibited stable mor-
phologies in normal physiological condition and could be
efficiently internalized by RenCa cells (a mouse renal car-
cinoma cell line). Moreover, all these formulations, espe-
cially SCM/DOX, showed excellent anti-proliferative
efficiency toward RenCa cells, which were even better
than free DOX · HCl. In addition, all the loading micelles
maintained excellent serum albumin-tolerance stability
and showed lower hemolytic rates compared with free




Four-armed PEG (number-average molecular weight
(Mn) = 10,000 Da) was obtained from Shanghai Seebio
Biotech, Inc. (Shanghai, People’s Republic of China) andused as received. DLA and LLA were provided by
Changchun SinoBiomaterials Co., Ltd. (Changchun,
People’s Republic of China) and recrystallized from ethyl
acetate under argon atmosphere before use. Four-armed
PEG-PDLA and PEG-PLLA were synthesized as our pre-
viously reported proposal [18]. The degree of polyme-
rization (DP) of PLA in each arm was calculated to be 16
based on the data of proton nuclear magnetic resonance
(1H NMR). The Mn of copolymer was estimated to be
14,600 g mol−1. Doxorubicin hydrochloride (DOX · HCl)
was purchased from Beijing HuaFeng United Technology
Co., Ltd. (Beijing, People’s Republic of China). 4′,6-Diami-
dino-2-phenylindole (DAPI), Alexa Fluor 488 phalloidin
(Alexa 488), and 3-(4,5-dimethylthiazol-2-y1)-2,5-diphe-
nyltetrazolium bromide (MTT) were purchased from
Sigma-Aldrich (Shanghai, People’s Republic of China).
RenCa cell line was obtained from the American Type
Culture Collection. Clear 6-well and 96-well tissue culture
polystyrene (TCP) plates were purchased from Corning
Costar Co. (Cambridge, MA, USA). The deionized water
used in this study was prepared through a Milli-Q water
purification equipment (Millipore Co., MA, USA).
Encapsulation of DOX
The encapsulation of DOX into these micelles was per-
formed through a nanoprecipitation method, which
was described in previous studies [19,20]. Typically,
100.0 mg of four-armed PEG-PDLA copolymer was dis-
solved in 10.0 mL of N,N-dimethylformamide (DMF)
(i.e., 10.0 mg mL−1), and then DOX · HCl (21.3 mg) dis-
solved in 6.0 mL of Milli-Q water was added dropwisely.
After that, 2.0 mL of phosphate-buffered saline (PBS) was
added into the mixed solution to neutralize the hydrochloric
acid in DOX ·HCl. The mixture was stirred at room
temperature for 12 h and subsequently dialyzed using a dia-
lysis bag (molecular weight cut-off (MWCO) = 3,500 Da)
against deionized water for 12 h. After freeze-drying,
PDM/DOX was obtained. PLM/DOX and SCM/DOX
were fabricated in the same way.
For determining the drug loading content (DLC) and
drug loading efficiency (DLE), the DOX-loaded micelles
were dissolved in DMF and stirred for 12 h at room
temperature in the dark. And then, the amount of DOX
in micelles were analyzed with fluorescence measure-
ments using a standard curve method on a Photon
Technology International (PTI) Fluorescence Master
System with software Felix 4.1.0 (λex = 480 nm; PTI,
Inc., Lawrenceville, NJ, USA). The DLC and DLE of the
DOX-loaded micelles were calculated according to the
following Formulas (1) and (2), respectively.
DLC wt:%ð Þ ¼ Weight of drug in micelle
Weight of drug‐loadedmicelle
 100 ð1Þ
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Measurements
The morphologies and sizes of the DOX-loaded micelles
were characterized by transmission electron microscopy
(TEM) and dynamic light scattering (DLS). For TEM
observation, 10.0 μL of the loading micelle solution
(0.1 mg mL−1) was placed on a copper grid and air-dried
at room temperature. The tests were carried out on a
JEOL JEW-1011 instrument (JEOL, Peabody, MA, USA)
operating at an accelerating voltage of 100 kV. For DLS
assays, the DOX-loaded micelles were dissolved in PBS
at pH 7.4, and the Dhs of the laden micelles with dif-
ferent incubation times were detected at 25°C on a
WyattQELS apparatus. The intensity results were used,
and the average histograms were shown. The PDI of Dh
was referred as the ratio of standard deviation and the
mean of Dh.
In vitro DOX release
The release profiles of the DOX-loaded micelles were
studied using a dialysis bag (MWCO= 3,500 Da) at
pH 7.4. In brief, 1.0 mg of PDM/DOX, PLM/DOX, or
SCM/DOX was dissolved in 10.0 mL of PBS and then
transferred into the dialysis bag (MWCO= 3,500 Da).
The dialysis bag was then put into 100.0 mL of PBS at
37°C with continuous vibrations of 70 rpm. At desired
time intervals, 2.0 mL of release medium was taken out,
and an equal volume of PBS was replenished. The release
of DOX was determined by fluorescence spectroscopy.
Intracellular DOX release analyses
The cellular uptakes of the DOX-loaded micelles and
free DOX · HCl were qualitatively detected by confocal
laser scanning microscopy (CLSM) and quantitatively
estimated by flow cytometry (FCM) toward RenCa cells.
CLSM
The RenCa cells were seeded on glass coverslips at a
density of 2.0 × 105 cells per well in 2.0 mL of com-
plete high glucose Dulbecco’s modified Eagle’s medium
(HG-DMEM) in 6-well plates for 24 h. PDM/DOX, PLM/
DOX, SCM/DOX, or free DOX · HCl with a DOX · HCl
dosage of 10.0 μg mL−1 was added to each well. After
coincubation for 2 h, the medium was removed, and the
cells on glass coverslips were washed with PBS five times
and immobilized by 4% (W/V) PBS-buffered paraformal-
dehyde for 20 min at room temperature. And then, the
cells were washed with PBS five times and reacted with
0.1% (V/V) Triton X-100 in PBS for 12 min at room
temperature. The nuclei were then stained with DAPI for
3 min at 37°C, after which the cells were washed with PBSfive times. At last, the filamentous actin was stained with
Alexa 488 for 30 min at 37°C and washed with PBS five
times. The fluorescence was observed with a LSM 780
CLSM (Carl Zeiss, Jena, Germany). Additionally, to further
monitor the intracellular DOX release of these micelles
with the time, PDM/DOX, PLM/DOX, SCM/DOX, or free
DOX · HCl with a DOX · HCl dosage of 1.0 μg mL−1 was
coincubated with the cells. After coculture for 2, 6, 12, or
24 h, the cells were detected as mentioned above.
FCM
RenCa cells were seeded in 6-well plates at a density
of 2.0 × 105 cells per well and cultured with 2.0 mL
of complete HG-DMEM for 24 h. And then, PDM/
DOX, PLM/DOX, SCM/DOX, or free DOX · HCl with
a DOX · HCl dosage of 10.0 μg mL−1 was added to each
well. The cells without any treatment were set as control.
After a 2 h coculture, the medium was removed, and the
cells were washed five times with PBS and then digested by
trypsin. Subsequently, 1.0 mL of PBS was added and col-
lected in centrifuge tubes for centrifugation at 3,500 rpm
for 5 min. After removing the supernatants, the bottom
cells were resuspended in 0.3 mL of PBS and examined by
a flow cytometer (λex = 488 nm; Beckman, CA, USA).
Cytotoxicity assays
The cytotoxicities of blank micelles were tested by a MTT
assay on RenCa cells with a final concentration from 1.6
to 100.0 μg mL−1. In brief, the cells were seeded on a
96-well plate at a density of 8.0 × 103 cells in 180.0 μL of
HG-DMEM and incubated at 37°C for 24 h. And then,
20.0 μL of micelle solutions at different concentrations
were added to each well and cultured for another 48 h.
Subsequently, 20.0 μL of MTT at a concentration of
5.0 mg mL−1 was added to each well. After incubation for
another 4 h, the medium was carefully removed, and
150.0 μL of dimethyl sulfoxide (DMSO) was added. After
vibration for 5 min, the absorbance of medium was deter-
mined at 490 nm using a Bio-Rad 680 microplate reader.
In addition, the in vitro antineoplastic activities of the
DOX-loaded micelles and free DOX · HCl with a DOX ·
HCl dosage of 0.16 to 10.0 μg mL−1 were also assessed on
RenCa cells following the above protocol. The cell viability
was calculated as Formula (3).
Cell viability %ð Þ ¼ Asample
Acontrol
 100 ð3Þ
In Formula (3), Asample and Acontrol represented the
absorbances of sample and control wells, respectively.
Serum albumin-tolerance stability assays
The stability of the laden micelles in the PBS-buffered
bovine serum albumin (BSA) solution (30.0 mg mL−1)
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time points.
Hemolytic activity tests
The hemolytic activities of PDM/DOX, PLM/DOX,
SCM/DOX, and free DOX · HCl were tested by a spec-
trophotometry technique. Typically, the fresh rabbit
blood obtained from the Experimental Animal Center of
Jilin University was stabilized with dipotassium ethylene
diamine tetraacetate (EDTAP) in normal saline (NS).
After being centrifuged at 1,500 rpm for 10 min, the
obtained red blood cells (RBCs) were carefully washed
and diluted with NS. And then, the various concentra-
tions of PDM/DOX, PLM/DOX, SCM/DOX, and free
DOX · HCl were added into the suspension of RBCs atFigure 1 Schematic illustration for construction of PDM/DOX, PLM/DOX, and S37°C for 2 h. NS was used as negative control, and Triton
X-100 (i.e., a lysing agent of RBCs) was used as positive
control. After centrifugation at 3,000 rpm for 10 min,
180.0 μL of the supernatant from each sample was col-
lected into a 96-well plate. Then the free hemoglobin in
supernatant was tested at 570 nm by a Bio-Rad 680 micro-
plate reader (Hercules, CA, USA). The hemolytic ratio of
RBCs was calculated as Formula (4).




In Formula (4), Asample, Anegative control, and Apositive con-
trol represented the absorbances of sample, and negative
and positive controls, respectively.CM/DOX, and cellular uptakes and intracellular DOX release in RenCa cells.
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All tests were carried out independently at least three
times, and the data were expressed as mean ± standard
deviation (SD). The data were analyzed for statistical
significance using SPSS (Version 13.0, USA). &p < 0.05
was considered statistically significant, and #p < 0.01 and
*p < 0.001 were considered highly significant.
Results and discussion
Preparations and characterizations of DOX-loaded
micelles
The branched and multi-armed copolymers have gained
more and more attention for their more excellent rheo-
logical, mechanical, and biomedical properties than the
linear ones [21-23]. In this study, two enantiomeric four-
armed copolymers of PEG-PDLA and PEG-PLLA were
explored as the matrices of nanocarriers for the con-
trolled delivery of antineoplastic drug into RenCa cells.Figure 2 Typical TEM micrographs (A, B, and C) and Dhs (D, E, and F) ofThe four-armed PEG-PDLA and PEG-PLLA, and an
equimolar mixture of the above two copolymers were
prone to self-assemble into micelles in aqueous solution
because of the amphiphilic nature, which were noted as
PDM, PLM, and SCM, respectively. The CMCs of PDM,
PLM, and SCM were detected to be 4.5 × 10−3, 3.6 × 10−3,
and 1.7 × 10−3 mg mL−1, respectively. Compared with
PDM and PLM, SCM showed the lowest CMC, which
should be attributed to the formation of tightly packed
hydrophobic core enhanced by the stereocomplex
interaction.
A model antineoplastic agent, i.e., DOX, was physically
encapsulated into PDM, PLM, or SCM through nano-
precipitation, and the DOX-loaded micelles were referred
as PDM/DOX, PLM/DOX, and SCM/DOX, respectively.
The process was illustrated in Figure 1. The DLCs of
PDM/DOX, PLM/DOX, and SCM/DOX were calculated
to be 8.5, 8.9, and 10.1 wt.%, and the DLEs of them werePDM/DOX (A and D), PLM/DOX (B and E), and SCM/DOX (C and F).
Figure 3 Dh changes of PDM/DOX, PLM/DOX, and SCM/DOX
versus time in PBS at pH 7.4, 25°C. Each datum was represented
as mean ± SD (n = 3).
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stable stereocomplex crystallization of enantiomeric PLA
in micellar core induced higher DLC and DLE of SCM/
DOX [16]. The morphologies and sizes of the DOX-
loaded micelles were characterized by TEM and DLS. As
shown in Figure 2A, 2B, and 2C, the TEM micrographs
showed that PDM/DOX, PLM/DOX, and SCM/DOX
took clear spherical morphologies with the respective
average sizes of approximately 100, 90, and 75 nm, re-
spectively. In contrast, the DLS measurements showed
that the mean diameters of laden micelles were 115 ± 4.6,
105 ± 4.4, and 90 ± 4.2 nm, respectively (Figure 2D, 2E,
and 2F). The SCM/DOX exhibited the smallest size. This
might be related to the formation of stereocomplex, which
strongly improved the stability of copolymer [17,24].
Moreover, the polydispersity indices (PDIs) of Dhs wereFigure 4 Release behaviors of PDM/DOX, PLM/DOX, and SCM/DOX in
PBS at pH 7.4, 37°C. Each datum was represented as mean ± SD (n = 3).calculated to be 0.15, 0.14, and 0.12, respectively, which
indicated the narrow size distribution of these loading mi-
celles. Bigger values from DLS detections compared with
those from TEM measurements should be attributed to
the hydration state of micelles [25]. The sizes of these
laden micelles were appropriate for them to passively tar-
get in tumor tissues through the enhanced permeability
and retention (EPR) effect [26]. Moreover, as shown in
Figure 3, all these laden micelles demonstrated nearly con-
stant diameters during the incubation in PBS at pH 7.4 for
72 h, which indicated the excellent stability of the test
laden micelles.
Drug release profiles from laden micelles
The release of DOX from laden micelles was inves-
tigated in PBS at pH 7.4, 37°C (Figure 4). It could beFigure 5 Typical CLSM microimages (A) and FCM determinations
(B) of RenCa cells incubated with PDM/DOX, PLM/DOX, SCM/DOX,
or free DOX · HCl for 2 h.
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PLM/DOX showed three phases: i) a fast release stage,
in which about 55 and 45% of loaded DOX were released
during the first 5 h, respectively; ii) a continuously slow
release phase, in which 65 and 55% of loaded DOX wereFigure 6 Intracellular DOX internalization of PDM/DOX, PLM/DOX, SCM/DO
time (A), and statistical analysis of optical density of DOX fluorescence intensi
and *p < 0.001).released before 25 h, respectively; iii) a platform period, in
which only a little loaded DOX was released until 72 h.
The initial fast release was considered to be relevant to
the absorption of DOX by the shallow parts of micelles.
The slow release behavior might be attributed to theX, and free DOX · HCl groups after coculture for different periods of
ty (B). The data were shown as mean ± SD (n = 4; &p < 0.05, #p < 0.01,
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degradation of PLA block [27]. Compared with PDM/
DOX and PLM/DOX, SCM/DOX exhibited weaker ini-
tial burst release and slower sustained release rate in
72 h, which might be relevant to the enhanced stability
of SCM [24]. Therefore, SCM represented as a great
promising approach to efficiently load and controllably
release antineoplastic drugs.
The cellular uptakes and intracellular release behaviors
of the DOX-loaded micelles toward RenCa cells were
evaluated using CLSM and FCM to validate whether
these laden micelles were effective to deliver DOX into
cells. From the CLSM microimages in Figure 5A, a
stronger intracellular DOX fluorescence intensity was
observed after incubation with SCM/DOX for 2 h than
those with the DOX-loaded micelles with single compo-
nent. This result was possibly relevant to slower extra-
cellular DOX release and more efficient intracellular
DOX release. In contrast, the intracellular DOX fluores-
cence intensity of the free DOX · HCl group was a little
stronger than that of the SCM/DOX one after coincuba-
tion for 2 h. It was because that the cellular uptake of free
DOX · HCl by diffusion was faster than the endocytosis of
DOX-incorporated micelles in a relatively short detection
time [28]. To further prove our statement, the FCM
histograms of the loading micelles and free DOX · HCl
were analyzed. As shown in Figure 5B, the signal intensity
of SCM/DOX was stronger than those of PDM/DOX
and PLM/DOX, and there was little difference between
those of the PDM/DOX and PLM/DOX groups. The free
DOX · HCl group exhibited the highest fluorescence
intensity after coculture for 2 h that was agreed very well
with the results of CLSM. The data of CLSM and FCM
proved the effective internalization of the laden micelles
by RenCa cells.Figure 7 Relative cell viabilities of blank micelles (A), and DOX-loaded mic
as mean ± SD (n = 4; *p < 0.001).In addition, a relatively low dosage of DOX · HCl, i.e.,
1.0 μg mL−1, was used for testing the intracellular DOX
release within 24 h, which aimed to avoid the death of
cells with a longer time of incubation. As shown in
Figure 6A, the free DOX · HCl group exhibited the high-
est intracellular DOX fluorescence intensity compared
with the laden micelle ones after incubation for 2 h
(p < 0.05). Until 12 h, the intracellular DOX fluorescence
intensity of the free DOX · HCl group was stronger than
those of the loading micelle groups (p < 0.05), although
the laden micelle groups showed a gradually increased
intensity with the extension of time. More interestingly,
the results were reversed after 24-h culture, that is, the
DOX-loaded micelle groups, especially, the SCM/DOX
one, showed stronger intracellular DOX fluorescence in-
tensity than the free DOX · HCl group (p < 0.001). The
SCM/DOX group exhibited a higher signal than those of
the laden micelles with single component for all the test
time points (p < 0.05). Moreover, the quantification of
DOX fluorescence intensity was shown in Figure 6B.
The relative optical density of DOX fluorescence in-
tensity was analyzed with ImageJ software (National
Institutes of Health, Bethesda, Maryland, USA). The intra-
cellular DOX fluorescence intensity of the free DOX · HCl
group after coincubation for 2 h was set as “1”. These re-
sults further demonstrated that these laden micelles, espe-
cially SCM/DOX, could achieve efficiently intracellular
DOX release with a longer intracellular responding time.
In vitro antineoplastic activities toward RenCa cells
DOX, a widely used small molecule anthracycline anti-
neoplastic agent in clinic, is known to play an important
role through the intercalation and inhibition of macro-
molecular biosynthesis of DNA [29]. The in vitro cyto-
toxicities of blank micelles, DOX-loaded micelles, andelles and free DOX · HCl (B) toward RenCa cells. The data were shown
Figure 9 Hemolytic behaviors of PDM/DOX (A), PLM/DOX (B), SCM/DOX (
Figure 8 Dh changes of PDM/DOX, PLM/DOX, and SCM/DOX versus
time in PBS-buffered BSA solution (30.0 mg mL−1) at pH 7.4, 25°C.
Each datum was represented as mean ± SD (n = 3).
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MTT assay. As depicted in Figure 7A, blank micelles did
not show obvious toxicities toward RenCa cells even at a
high concentration up to 100.0 μg mL−1 after cocultu-
ring for 48 h, indicating their excellent biocompatibility.
As shown in Figure 7B, compared to free DOX · HCl,
the laden micelles appeared a stronger proliferation in-
hibitory efficacy at equivalent DOX concentration after
incubation for 48 h (p < 0.001). Moreover, SCM/DOX
showed more effective proliferation inhibition efficacy
on RenCa cells than those of the DOX-loaded micelles
with single component (p < 0.001). It might be attributed
to a higher extracellular stability of SCM than the mi-
celles with single component. A greater stability guaran-
teed a larger amount of laden SCM to be internalized
into the RenCa cells by endocytosis and more persistent
DOX to release in tumor cells, which was consistent
with the DOX release profiles of the laden micelles in
PBS (Figure 4). At higher DOX · HCl concentrations,
that is, 2.5 to 10 μg mL−1, it appeared to be little differ-
ence in the antineoplastic activity among all the test for-
mulations (p > 0.05). It was because that DOX exhibitedC), and free DOX · HCl (D).
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2.5 μg mL−1, and the continuously increased intracellular
DOX concentration could not further improve the anti-
neoplastic activities of all the DOX formulations. The
half maximal inhibitory concentrations (IC50s) of PDM/
DOX, PLM/DOX, SCM/DOX, and free DOX · HCl were
calculated to be 0.43, 0.34, 0.24, and 0.64 μg mL−1, re-
spectively. The lowest IC50 also quantitatively proved the
more effective antineoplastic efficacy of SCM/DOX.
Evaluations of serum albumin-tolerance stability and
hemocompatibility
The evaluations of serum albumin-tolerance stability
and hemocompatibility are critical for the DOX-loaded
micelles to be applied in clinic because these corre-
sponding formulations are designed to be administrated
intravenously [30]. In this study, the stability of these
laden micelles was tested by DLS in the PBS-buffered
BSA solution at a concentration of 30.0 mg mL−1, 25°C.
As shown in Figure 8, all the loading micelles exhibited
excellent stability among the measurement of 72 h, which
were around 115, 105, and 90 nm, respectively. Moreover,
the Dhs of these laden micelles in PBS with BSA were
similar with the above results in PBS without BSA
(Figure 3). The results indicated that the DOX-loaded
micelles could keep excellent stability in BSA solution.
Moreover, as shown in Figure 9, all these laden mi-
celles exhibited no obvious hemolytic activities with the
DOX · HCl concentrations up to 1,000 μg mL−1. In con-
trast, free DOX · HCl exhibited more serious hemolytic
performance at the concentration over 2.5 mg mL−1,
which adequately exceeded the final anticipated concen-
tration of drug administrated by intravenous injection
in vivo [30]. It indicated that the DOX-loaded micelles
had satisfactory blood compatibility, which was suitable
for the clinical application.
Conclusions
In this work, the DOX-loaded micelles, i.e., PDM/DOX,
PLM/DOX, and SCM/DOX, were successfully designed
and prepared from nonlinear enantiomeric PEG-PLA
copolymers. The diameters of the loading micelles were
approximately 100 nm, which were suitable for the se-
lective accumulation in neoplasm tissue through the
EPR effect. Compared to PDM/DOX and PLM/DOX,
SCM/DOX exhibited smaller diameter, slower DOX re-
lease in vitro, and more effective internalization by RenCa
cells. Furthermore, SCM/DOX achieved more effective
intracellular release of DOX and showed the enhanced
cellular proliferation inhibition toward RenCa cells than
PDM/DOX, PLM/DOX, and free DOX · HCl. Moreover,
all the laden micelles held excellent serum albumin-
tolerance stability and exhibited satisfactory hemocom-
patibility compared to free DOX · HCl. With moreeffective intracellular DOX release, improved antineoplas-
tic activity, and good biocompatibility, the micelles, espe-
cially SCM, might become an effective drug delivery
platform of antineoplastic drug for the clinical
chemotherapy.
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